MMRF: Novel Drug Screening

There are many "libraries" of FDA-approved drugs and other compounds that may hold potential to treat myeloma. When we learned they had not been tested in myeloma, we immediately set into action an innovative drug screening program of these drugs against known myeloma targets. We are now working closely with leading academic institutions to rapidly screen these compounds, and by February of 2006, we will know which types of compounds show potential activity in myeloma.

Source: MMRF mailing